CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK

Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

01 نوفمبر 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Appoints Monica Tellado as President, Emerging Markets

01 نوفمبر 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)

26 أكتوبر 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call

25 أكتوبر 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

02 أغسطس 2023 13:05:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

26 يوليو 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)

17 يوليو 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer

27 يونيو 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update

03 مايو 2023 13:05:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

26 أبريل 2023 13:05:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Final Results of Tender Offer

05 أبريل 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Preliminary Results of Tender Offer

03 أبريل 2023 05:00:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Initiates CATALYST Clinical Trial

28 مارس 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock

06 مارس 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update

28 فبراير 2023 13:05:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call

14 فبراير 2023 13:05:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation

13 فبراير 2023 05:00:00 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Provides Miricorilant Clinical Development Update

08 ديسمبر 2022 05:00:02 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals

08 ديسمبر 2022 05:00:01 بحسب Nasdaq GlobeNewswire

Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

03 نوفمبر 2022 13:05:02 بحسب Nasdaq GlobeNewswire